IFNA2 and COVID-19: Utilizing mass cytometry and Nanostring technology, Hadjadj et al. performed immune profiling of 50 COVID-19 patients and observed an impaired IFNα/β response in severe and critically ill patients, compared to those with mild to moderate disease (24).